|
Volumn 24, Issue 11, 1999, Pages 557-566
|
Quinupristin/Dalfopristin: A new therapeutic option for serious hospital-acquired infections
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
ANTIBIOTIC AGENT;
CEFOTAXIME;
CEFTRIAXONE;
CEPHALOSPORIN DERIVATIVE;
CLINDAMYCIN;
COTRIMOXAZOLE;
DALFOPRISTIN PLUS QUINUPRISTIN;
IMIPENEM;
MACROLIDE;
METICILLIN;
PENICILLIN DERIVATIVE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
STREPTOGRAMIN;
TETRACYCLINE DERIVATIVE;
VANCOMYCIN;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
BACTERIAL INFECTION;
BACTERIAL PNEUMONIA;
BONE INFECTION;
CLINICAL TRIAL;
DRUG INDUCED DISEASE;
ENTEROCOCCUS FAECALIS;
GRAM POSITIVE BACTERIUM;
HOSPITAL INFECTION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
REVIEW;
SKIN INFECTION;
STAPHYLOCOCCUS EPIDERMIDIS;
STREPTOCOCCUS PNEUMONIAE;
|
EID: 0032753614
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (42)
|